Semaglutide
GTM-021
Unknown small_molecule active
Quick answer
Semaglutide for Obesity (Disorder) is a Unknown program (small_molecule) at GT Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GT Biopharma
- Indication
- Obesity (Disorder)
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active